SCARCITY PROFILE — SCIENTIFIC LEADERSHIP

Olimpia Baranowska — CEO & Principal Scientist, Olympia Biosciences

Olimpia Baranowska

CEO · SCIENTIFIC DIRECTOR · FOUNDER

M.Sc. Eng. in Technical Physics and Applied Mathematics and Ph.D. Candidate in Medical Sciences (Phlebology), recognized in Rome for scientific excellence. Built a 17-year operating record while engineering a pure-play B2B CDMO model for defensible, clinical-grade IP mandates.

LEADERSHIP ACCESS PROTOCOL

Not a public founder inbox. A filtered scientific mandate pipeline.

Consultation is led by the CEO or a dedicated Lead Project Manager, depending on project phase and requirements.

AUTO-DECLINED INTAKE

  • GENERAL NETWORKING REQUESTS WITHOUT EXECUTION MANDATE
  • PRICE-FIRST OUTREACH WITHOUT CLINICAL OR IP THESIS
  • PRIVATE-LABEL OR LOW-MOQ INQUIRIES SEEKING OPEN INTAKE
  • FREE CONSULTATION EXPECTATIONS DISGUISED AS DUE DILIGENCE

ADMISSION REQUIREMENTS

BOARD-SPONSORED PROGRAM WITH BUDGET AUTHORITY
DEFENSIBLE SCIENTIFIC OR M&A-READY IP OBJECTIVE
READINESS FOR REGULATORY, QA, AND SCALE-UP GOVERNANCE
COMMITMENT TO START WITH PAID DUE DILIGENCE

CREDENTIAL MATRIX

Physics precision fused with medical rigor.

MSc ENGINEERING

APPLIED PHYSICS AND APPLIED MATHEMATICS — GDAŃSK UNIVERSITY OF TECHNOLOGY | DOUBLE SPECIALIZATION: ABSTRACT QUANTUM PHYSICS & ORGANIC MICROELECTRONICS

PHD TRACK

MEDICAL SCIENCES — DOCTORAL STUDIES | SPECIALIZATION: PHLEBOLOGY (BIOPHYSICS · PHARMACOGENETICS · CLINICAL EFFICACY)

STRATEGIC INNOVATIONS

Built as enterprise moat, not marketing story.

FOUNDER SYNTHESIS

NON-LINEAR INTEGRATION OF PHYSICS, COLLAGEN BIOCHEMISTRY, PHLEBOLOGY AND MANUFACTURING.

HUMAN-LED, AI-ENABLED

HUMAN ORIGINALITY DEFINES DIRECTION; AI ACCELERATES EVIDENCE MAPPING.

PROPRIETARY TECHNOLOGY

OWNED NATIVE-COLLAGEN PROCESS KNOW-HOW AND REGISTERED INNOVATION MARKS.

SCIENTIFIC PHILOSOPHY

“Most contract manufacturers in this market are run by commercial teams optimising volumes. I am a technical physicist and medical researcher by training — I entered business only because no one else could transfer laboratory rigor to industrial scale. For me, a formula is not a marketing tool; it is a scientific hypothesis that must be uncompromisingly validated before it enters production. If a given composition does not hold up in peer-reviewed clinical research, I simply will not manufacture it — regardless of the client's budget.”
Olimpia Baranowska

Olimpia Baranowska

CEO & Scientific Director — IOC Ltd.

EXTERNAL VALIDATION

Recognition from institutions, not vanity rankings.

International Leader in Scientific Excellence

International Businesswoman Awards, Rome

Awarded for scientific leadership and the Zero Conflict manufacturing model.

Best in Business Award

Międzynarodowa Agencja Rozwoju

Best in Business Award 2025, presented during the LET'S TALK ABOUT IT congress, an event held under honorary patronage of the National Centre for Research and Development (Poland) and other institutions.

Business Growth Award — Chemical Industry

European Business Institute

Top dynamic growth in the chemical industry sector.

5,000 Most Dynamic Companies in Poland

European Business Institute

National ranking of fastest-growing enterprises.

Business Growth Award — Chemical Industry (2021)

European Business Institute

Consecutive year of recognition for dynamic growth (1966% dynamics).

Business Growth Award — Regional

European Business Institute

Regional leader in business growth.

Effective Company — Chemical Industry

European Business Institute

Recognition for operational efficiency and multi-year financial stability.

LEADERSHIP ACCESS

If your mandate is serious, initiate due diligence.

Consultation is led by the CEO or a dedicated Lead Project Manager, depending on project phase and requirements.

Frequently Asked Questions

Who is Olimpia Baranowska and what is her role at Olympia Biosciences™?
Olimpia Baranowska is the Co-Founder, CEO and Scientific Director of Olympia Biosciences™. She holds an M.Sc. Eng. in Technical Physics and Applied Mathematics and is a Ph.D. Candidate in Medical Sciences (Phlebology). Consultation is led by the CEO or a dedicated Lead Project Manager, depending on project phase and requirements. In 2025, she received the International Leader in Scientific Excellence in Dietary Supplement Manufacturing distinction at the International Businesswoman Awards in Rome.
What is the Zero Conflict of Interest model and why does it matter for supplement brands?
Olympia Biosciences™ operates a pure-play B2B model and owns zero consumer brands.
What scientific publications has Olimpia Baranowska authored?
Olimpia Baranowska has authored scientific and industry publications on collagen science (Biotechnologia.pl — 3 papers), pharmacogenetics and personalized medicine (Pharmaceutical Industry World), nervous system supplementation, hyperbaric oxygen therapy (Practical Physiotherapy), and collagen market analysis. Her research spans nutraceutical chemistry, biophysics, and clinical applications.
What international awards has Olimpia Baranowska and Olympia Biosciences™ received?
Verified distinctions include the International Leader in Scientific Excellence in Dietary Supplement Manufacturing 2025, awarded in Rome, and the Best in Business Award 2025, awarded by Międzynarodowa Agencja Rozwoju to IOC sp. z o.o. The LET'S TALK ABOUT IT congress at which the Best in Business Award was presented was held under honorary patronage of the National Centre for Research and Development (Poland) and other institutions.